Research Insights

Research Insights section focuses on the cutting-edge and breakthrough research that is happening all over the world. Laboratories across the globe are working hard to develop drugs and therapies for various diseases and research insights directly from them add tremendous value.

Bioactivity-driven Prediction of Antibacterial Synergy Using Machine Learning Models

Combination therapies have demonstrated improved efficacy across diverse clinical settings Predicting antibacterial drug synergy remains difficult due to strain variability and the limited scale of experimentally tested combinations

Robust Prediction of Drug Combination Side Effects in Realistic Settings

Side effects caused by drug combinations pose a major challenge in healthcare Knowledge of these side effects is limited because often they are not detected in clinical trials which typically involve a restricted number of participants and tested drug combinations

Identifying Severe COVID-19 Risk Variants Modulating Enhancer Reporter Activity in Lung Cells

Common genetic variants contribute to risk for complex human diseases However despite thousands of associations variants modulating disease risk and their functional impact remain largely unknown

Multi-regional Transcriptomic Profiling Reveals Divergent Molecular Mechanisms in ALS-related Neurodegeneration

Neurodegenerative disorders including amyotrophic lateral sclerosis ALS remain largely unsolved with complex etiology yet to be fully elucidated The most common genetic cause of ALS in both familial and sporadic cases is the expansion of a hexanucleotide repeat in the Corf gene

Leveraging Bioinformatics Approaches for Drug Repositioning in Space Radiation Protection

The health effects of space radiation primarily Galactic Cosmic Rays GCRs on humans remain largely unknown with potential cardiovascular consequences posing a significant threat to astronauts

A Genomic-led Strategy to Anticipate Drug Safety Effects

Safetyrelated issues account for approximately of failures in new drug discovery programs On top of that many are discovered during postmarketing surveillance significantly limiting

Exploration of Acetylation-related Biomarkers in Osteoarthritis Through Bioinformatics Analysis

Osteoarthritis OA is characterized as a chronic degenerative disorder affecting the joints A growing body of evidence indicates that acetylation may play a role in the diseases pathogenesis However the underlying

Integrating multi-type features and knowledge graph for graded prediction of drug-induced liver injury in humans

Druginduced liver toxicity poses a threat to human health and remains a significant reason for drug withdrawal from the market Therefore early identification of druginduced liver injury DILI during drug development is crucial However

Tissue-specific Transfer Learning Improves Functional Variant and Therapeutic Target Discoveries in Breast and Prostate Cancer

DNA foundation models trained on largescale genomic and epigenetic datasets have shown promise for regulatory variant interpretation yet their application to tissuespecific contexts remain limited

DNA Oligonucleotides Block Viral Entry of SARS-CoV-2 Omicron Variants

Successful viruses including SARSCoV antagonize and evade immune detection to establish infection As population immunity to the ancestral strain has risen new variantsparticularly Omicron